The endometrial cancer A230V-ALK5 (TGFBR1) mutant attenuates TGF-β signaling and exhibits reduced in vitro sensitivity to ALK5 inhibitors
Eun‐Jeong Yu(National Institutes of Health), Daphne W. Bell(National Institutes of Health)
Cited by 1
Related Papers
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Detection of Mutations in <i>EGFR</i> in Circulating Lung-Cancer Cells
|New England Journal of Medicine|2008|1.6k
A recurrent mutation in PALB2 in Finnish cancer families
|Nature|2007|461
Genetic and functional analysis of <i>CHEK2</i> (<i>CHK2</i>) variants in multiethnic cohorts
|International Journal of Cancer|2007|90